Xydalba

DRUG3 trials

Sponsors

Correvio International Sarl, Aziende Chimiche Riunite Angelini Francesco S.p.A

Conditions

Acute Bacterial Skin and Skin Structure InfectionBacterial Infections

Unknown Phase

Xydalba Utilization Registry in Germany

TerminatedNCT03696901

Correvio International SarlBacterial Infections

Start: 2018-11-21End: 2020-04-07Updated: 2020-07-17

Xydalba Utilization Registry in France

CompletedNCT03726216

Correvio International SarlBacterial Infections

Start: 2018-09-06End: 2020-10-28Updated: 2021-07-20

Retrospective Effectiveness Study of Dalbavancin and Other Standard of Care of the Same Class in Patients With ABSSSI

CompletedNCT04298463

Aziende Chimiche Riunite Angelini Francesco S.p.AAcute Bacterial Skin and Skin Structure Infection

Start: 2020-06-18End: 2021-05-19Updated: 2022-03-04